Breakthrough Study Tests Pill That May Slow Ageing In Dogs
Loyal is testing a pill that could change how older dogs feel, and it is happening in real homes, not just lab glassware. The company’s LOY-002 drug is built around one big idea: slowing down the metabolic dysfunction that may drive aging.
But this is not a simple “try it and hope” situation. Loyal is running the STAY trial with vets nationwide, lining up a comparison group where some dogs get a placebo. That setup is what lets them tell the difference between genuine drug effects and the normal, boring decline that comes with getting older.
If the data keeps looking promising, the company could be aiming for an FDA decision in 2026, and that timeline turns “maybe” into something a lot more real.
Loyal is testing its ageing-dog drug with vets nationwide.
The company has partnered with veterinarians across the United States to collect detailed information on how the experimental drug affects older dogs. Like most robust scientific studies, the STAY trial includes a comparison group: not every dog receives the new treatment.
Some are given a placebo so that researchers can distinguish genuine drug effects from normal changes that occur as dogs age. Loyal emphasises that this kind of structure is crucial for understanding whether the treatment truly works.
Loyal’s STAY trial is already rolling through vet partners nationwide, and the placebo comparison is the part that makes dog owners pay attention.
Right now, the data from the STAY study is helping Loyal build the evidence needed to seek approval from the US Food and Drug Administration. Drug approval is never guaranteed, but the company is hoping for a decision sometime in 2026 if results remain promising.
If approved, this would mark a significant milestone not only for veterinary medicine but also for anyone who sees their pet as a beloved family member.
A new anti-ageing drug aims to help older dogs stay mobile, energetic, and healthier for longer.
The drug being tested, known as LOY-002, is designed for older dogs of almost every size and breed. It targets metabolic dysfunction, which scientists believe plays an important role in how quickly dogs age.
By improving the way a dog’s body manages energy and cellular processes, the treatment could help maintain mobility, vitality, and overall wellness in the later stages of life. The goal is not to create dogs that live forever, but to support healthier years and slow down the decline that often comes with ageing.
The complicated bit is that the researchers need enough detailed info to prove LOY-002 is doing more than just making older dogs seem “a little better.”
This also echoes the fight between a husband who set up a shock collar and the woman who refused to test it
, despite him insisting she feel the shock.When the trial data starts shaping Loyal’s FDA submission, the hope is no longer vague, it is scheduled for a potential 2026 verdict.
Celine Halioua, the founder and chief executive of Loyal, has been straightforward about what the company hopes to achieve. In a previous interview with The Guardian, she explained that the goal is not immortality but healthier longevity. That shift could translate into meaningful extra years spent walking, playing, and enjoying time with their families.
And once you hear the founder’s goal of “healthier longevity,” the whole story shifts from aging as inevitability to aging as something they can slow down.
For many dog owners, even the idea of adding more quality years to a pet’s life is deeply meaningful. While the research is still ongoing, Loyal’s work represents a growing belief in the scientific community that ageing itself can be influenced, not just endured.
If this drug succeeds, it could open the door to a new chapter in pet care - one where longer, healthier canine lives are not just a dream but a real possibility.
For once, the “good old days” might not have to end as quickly.
Before you judge pet “anti-aging” hype, read about the Ozempic-like dog implant debate, where supporters claim it’s a breakthrough and critics warn it promotes laziness.
Share this article:
